Archive for 2017

Cars Of World Leaders

By Jacob Wolinsky. Originally published at ValueWalk.

The classic image of a world leader involves a lot of being driven about in large, black, bulletproof limos. For most part this is accurate, and the majority of heads of state are driven to events in armoured Mercedes Benz vehicles.

With all eyes on Trump during his recent inauguration, it was very important that he had a tidy, clean car for his entrance to the global stage. The whole event was also dubbed a ‘two mile nightmare’ by the Secret Service, so security was paramount. Fortunately, his mechanical steed dubbed by many ‘The Beast’ and others ‘Cadillac One’ delivered.

Other leaders though, have different preferences. The Danish Royals are far more concerned with heritage, and cling to their classic 1958 Rolls-Royce Silver Wraith, known locally as the ‘Store Krone’ (‘Big Crown’ in English.) This vehicle has no serious security measures in place, but it’s undoubtedly stylish.

Chile too clings to an ancient 1966 Ford Galaxie, choosing classic aesthetics over function for national days of celebration. The car was originally purchased to seat Queen Elizabeth on a state visit in 1968. At a cost of just $9,200, the USA could purchase 163 of Chile’s state car for $1.5 million, the cost of one of Trump’s vehicles.

Some nations project different values entirely with their choice of state car. Until recently Jose Mujica, dubbed ‘the world’s poorest president’ drove himself to official events in his sky-blue 1987 VW Beetle. Despite receiving offers of over $1 million, Mujica’s ride’s approximate resale value is little over $1,800. The car embodied what Mujica’s presidency stood for, focusing on the nation’s poor over his own comfort.

Regtransfers, a UK-based number plate reseller has delved into the fascinating world of state cars in the infographic below. They’ve also included a fascinating map of which countries choose which brands of car for their leaders. It suggests that while the majority of nations opt for a Mercedes or other German vehicle, others stick to their national brands, notably the UK, USA, Czech Republic, China, France, Italy, South Korea, and Sweden.

There are perks to power, especially when it comes to automotive selection for the world’s heads of state.

The doors on President Trump’s technological marvel car, for example, are so heavy that he couldn’t even open them from the inside if he wanted to.

However…
continue reading





Will The Trump Administration Embrace The ‘One China’ Policy?

By Knowledge Wharton. Originally published at ValueWalk.

Penn’s Jacques deLisle and Wharton’s Minyuan Zhao discuss the latest developments in U.S.-China relations.


China’s leadership is urging U.S. President Donald Trump to embrace the “one China” policy on Taiwan and has warned the new administration that a trade war would raise the prices of many goods that Americans depend on, like iPhones. Jacques deLisle, a professor at the University of Pennsylvania Law School and director of Penn’s Center for East Asian Studies, and Minyuan Zhao, a Wharton management professor, recently appeared on the  Knowledge@Wharton show, part of Wharton Business Radio on SiriusXM channel 111, to discuss the latest economic developments in China and Chinese officials’ reactions to what is happening in Washington. (Listen to the podcast at the top of this page.)

China United states

Image source: Wikimedia Commons

Additional coverage:

Trump’s Mixed Signals on China: Is There a Strategy?

Can the U.S. and China Avoid a Trade War?

China in 2017: Why Stability – not Growth – Is the Goal

The Truth about China’s Role in Global Economic Turmoil

Article by Knowledge@Wharton

The post Will The Trump Administration Embrace The ‘One China’ Policy? appeared first on ValueWalk.

Sign up for ValueWalk’s free newsletter here.





Despite Attackers Yelling “Allahu Akbar”, Politicians Blame “Years Of Demonizing Muslims” For “Barbaric, Terrorist Act” In Quebec City Mosque

Courtesy of ZeroHedge. View original post here.

Update: One day after the prime minister welcome Muslims into the country, it appears Quebec Premier Philippe Couillard calls mosque shooting a “terrorist act”, and Greg Fergus, an MP in Quebec blamed “years of demonising Muslims” for the massacre…

Quebec MP says deadly shooting at mosque is “a terrorist act that is…the result of years of demonising Muslims” https://t.co/H9PEImfv7Z pic.twitter.com/mBhzq0I3CR

— Al Jazeera News (@AJENews) January 30, 2017

Quebec police confirm: “The premises are secure and the occupants have been evacuated. The investigation continues,” the SPVQ wrote on Twitter.

A witness, who asked to remain anonymous, told CBC’s French-language service Radio-Canada that two masked individuals entered the mosque.

“It seemed to me that they had a Quebecois accent. They started to fire, and as they shot they yelled, ‘Allahu akbar!’ The bullets hit people that were praying. People who were praying lost their lives. A bullet passed right over my head,” said the witness.

Additionally, NYPD is steeping up patrol at all mosque/house-of-worship locations citywide, due to the shooting at a mosque in Quebec.

*  *  *

As we detailed earlier, five people were killed after gunmen opened fire in a Quebec City mosque during evening prayers, the mosque’s president told reporters on Sunday Reuters reported. Police confirmed the shooting at a Quebec mosque in a tweet, confirming numerous fatalities.

“There are many victims … there are deaths,” a Quebec police‎ spokesman told reporters.

Quebec City Constable Étienne Doyon told reporters that police received a call around 7:55 p.m. on Sunday, stating that shots had been heard at the Centre Culturel Islamique de Québec on Sainte-Foy St.

Why is this happening here? This is barbaric,” said the mosque’s president, Mohamed Yangui. In June 2016, a pig’s head was left on the doorstep of the cultural centre, Reuters added. Yangui, who luckily was not inside the mosque during the shooting, said he received frantic calls from people at evening prayers. He said the injured had been taken to different hospitals across Quebec City.

Horrible news of a shooting at a mosque in Quebec. Details still being sorted out. https://t.co/dSxBYtyvyi

— Catherine Griwkowsky (@CGriwkowsky) January 30, 2017


continue reading





Mattress Market Cozying Up To Consolidation

Courtesy of Benzinga.

Mattress Market Cozying Up To Consolidation

Tempur Sealy International Inc (NYSE: TPX) is plunging over 28 percent after it announced that it is severing ties with its biggest retailer.

Snapping Ties

Tempur Sealy said in a release that following a deadlock in the negotiations between it and Mattress Firm Holding Corp (NASDAQ: MFRM), it had issued termination notices for all of its brands to Mattress Firm as of January 27.

Mattress Firm Holdings had earlier notified its intention to terminate all contracts with Tempur Sealy in the United States, if the latter did not agree to considerable changes to the agreements between the companies, including economic concessions.

Tempur Sealy expects that it will stop doing business with Mattress Firm in the first quarter of 2017. Giving details of the ties, the company noted that its sales to Mattress Firm represented 21 percent of its total sales on a worldwide basis in 2016, although declining 11 percent year-over-year.

Mattress Firm was bought by South African retailer Steinhoff for $3.8 billion in 2016. Tempur Sealy clarified that all the other Steinhoff-owned entities represented less than 0.5 percent of its total sales in 2016.

Q4, FY Guidance

Tempur Sealy also announced preliminary fourth-quarter and full-year results. For the fourth quarter, the company expects to report earnings of $61 million to $63 million and adjusted EBITDA of $135 million to $138 million on net sales of $770 million.

The company expects full year 2016 earnings of $200 million to $202 million and adjusted EBITDA of $519 million to $522 million on an estimated 1 percent drop in revenues to $3.13 billion.

Analysts, on average, estimate net sales of $740.95 million for the fourth quarter and $3.1 billion for the year.

Consolidation In Mattress Industry

The mattress market has been on a…
continue reading





Here’s Why Alphabet’s $845 Stock Is Still Undervalued

Courtesy of Benzinga.

Here's Why Alphabet's $845 Stock Is Still Undervalued

Alphabet Inc (NASDAQ: GOOGL) is among the tech industry’s leaders, but shares appear “attractively valued,” in view of the company’s “rapidly expanding businesses,” Argus’s Joseph Bonner said in a report. He maintained a Buy rating on the company, with a price target of $950.

Last week, Alphabet reported its quarterly top line 3 percent ahead of the consensus estimate, albeit missing EPS expectations. The company recorded 22 percent year-over-year growth in gross revenue to $26.1 billion. Bonner raised the EPS estimate for 2017 from $39.98 to $41.17.

Stock Seems Undervalued

Alphabet is among the leaders in the tech industry, along with Facebook Inc (NASDAQ: FB), Apple Inc. (NASDAQ: AAPL) and Amazon.com, Inc. (NASDAQ: AMZN).

“These companies have come to dominate new developments in mobile, public cloud, and big data analytics, as well as emerging areas such as artificial intelligence and virtual/augmented reality,” Bonner commented.

While bears believe Alphabet would be less successful in monetizing mobile search advertising than it has been with desktop search, so far mobile search advertising seems to be growing strongly, the analyst noted. He added that even Alphabet’s next-generation businesses, such as YouTube, Google Cloud and Google Play, “have all begun to generate significant revenue growth.”

Alphabet’s shares have appreciated about 18 percent over the past year, versus a 22 percent gain in the S&P 500.

“We believe that the shares remain attractively valued given the company’s rapidly expanding businesses,” Bonner wrote.

Latest Ratings for GOOGL

Date Firm Action From To
Dec 2016 Aegis Capital Initiates Coverage On Buy
Oct 2016 Credit Suisse Maintains Outperform
Sep 2016 Wedbush Downgrades Neutral Underperform

View More Analyst Ratings for GOOGL


View the Latest Analyst Ratings

Posted-In: Argus Joseph BonnerAnalyst Color Long Ideas Reiteration Analyst Ratings Trading Ideas Best of Benzinga





Stay Patient, Under Armour Investors; Your Time May Come Post-Q4 Earnings

Courtesy of Benzinga.

Stay Patient, Under Armour Investors; Your Time May Come Post-Q4 Earnings

Shares of Under Armour Inc (NYSE: UA) (NYSE: UAA) continue trading at multi-year lows due to near-term concerns surrounding the brand’s fundamentals and external macro factors — and this creates a buying opportunity.

According to Baird’s Jonathan Komp, Under Armour’s stock now looks attractive relative to the company’s growth profile, which includes an expected 20-percent revenue growth and 25-percent earnings per share growth after 2018.

However, now is not the time to be buying Under Armour’s stock, the analyst cautioned. Specifically, the setup in the stock could improve after Tuesday’s fiscal fourth-quarter earnings report, which may disappoint investors in certain areas.

Wait And Watch: Here’s Why

For example, apparel was likely hurt by the warm weather start in the quarter along with lingering impacts from The Sports Authority bankruptcy. Meanwhile, the company’s footwear revenue estimate (consensus of 37 percent versus 95 percent) is “aggressive,” especially as sales of the Curry 3 shoe line appears muted.

Komp continued that investors should look beyond Tuesday’s earnings report and focus on the various range of drivers ahead, including footwear innovation, a new partnership to sell at Kohl’s Corporation (NYSE: KSS) stores and its new Threadborne fabric. These initiatives should ease investor concerns about the company hitting its 2017 financial objectives.

“While we would wait until post-Q4 to be more aggressive, we believe the stock can work from current levels if UA proves an ability to deliver on current 2017 estimates,” Komp concluded.

Image Credit: By Maryland GovPics – Under Armour Opening, CC BY 2.0, via Wikimedia Commons

Posted-In: Apparel Apparel CompaniesAnalyst Color Earnings News Previews Analyst Ratings Trading Ideas Best of Benzinga





Chesapeake Energy Lower For Third Session In A Row

Courtesy of Benzinga.

Chesapeake Energy Corporation (NYSE: CHK) shares are trading lower by $0.45 (6 percent) at $.6.47 in Monday’s session.

The new is no specific news to account for the decline. Instead, it may be following the retreat in the broad market as well as the selloff in Crude Oil futures prices.

After putting in a pair of highs on January 25 ($7.26) and January 26 ($7.29), the issue lost the $7.00 level on January 27, ending that session at $6.92.

Following a weak open, it was unable to regain that closing price peaking at $6.86 and then resumed its move lower. It has continued to make lows for the day, with current one standing at $6.41.

Perhaps the issue is attempting to fill its void in price from its November 29 session, when its daily high was $6.41. The following day, it opened above that level and ended that session at $7.00.

Posted-In: Technicals Intraday Update Movers Trading Ideas





Who Is Jorge Paulo Lemann, And Why Might He Be Up To Something Big In 2017?

Courtesy of Benzinga.

Who Is Jorge Paulo Lemann, And Why Might He Be Up To Something Big In 2017?

If history repeats itself, Jorge Paulo Lemann is up to something big.

Lemann is a Brazilian billionaire and co-founder of 3G Capital, a multi-billion-dollar investment firm that has teamed up with the American billionaire investor Warren Buffett in the past.

As noted by Bloomberg, Lemann worked with Buffett in 2013 to acquire H.J. Heinz. In 2015, the two worked together and orchestrated the $55 billion merger of Heinz and Kraft (previously Kraft Heinz Foods Co (NYSE: HNZ), now Kraft Heinz Co (NASDAQ: KHC)).

Notice a pattern? Every two years, Lemann and Buffett teamed up to make a major move in the food industry, and some analysts are optimistic the trend will continue in 2017.

In fact, traders appear to be on edge and the slightest indication of a deal was met with a surge of buying activity.

Last month shares of Mondelez International Inc (NASDAQ: MDLZ) spiked following a report in a little-known Swiss economic magazine called Bilanz which suggested Lemann and Buffett can team up to acquire the maker of Oreos and other food products.

Bloomberg added that even The Coca-Cola Co (NYSE: KO), a core holding in Buffett’s portfolio going back decades, could be in play for a buyout.

Bloomberg further noted that Lemann is an expert at boosting profits, to the point where companies need to change the way they conduct business or risk becoming a buyout target.

And Buffett’s $85 billion cash hoard technically makes any deal possible at this point.

“It’s logical that this would be the year,” David Palmer, a food industry analyst at RBC Capital told Bloomberg.

Posted-In: 3G Capital Bilanz Bloomberg David PalmerNews Rumors M&A Media Best of Benzinga





20 Biggest Mid-Day Losers For Monday

Courtesy of Benzinga.

  • Ocera Therapeutics Inc (NASDAQ: OCRX) shares dropped 68.3 percent to $0.650 after the company reported top-line results for Phase 2b study in Hepatic Encephalopathy.
  • Regulus Therapeutics Inc (NASDAQ: RGLS) shares declined 50 percent to $1.12 after the company received a written communication from the U.S. Food and Drug Administration that the clinical development for the company’s RG-101 remains on clinical hold.
  • Pulmatrix Inc (NASDAQ: PULM) declined 27.9 percent to $2.43 after surging 51.80 percent on Friday. Pulmatrix reported a $5 million registered direct offering.
  • Tempur Sealy International Inc (NYSE: TPX) shares dipped 27.6 percent to $45.74 following announcement of termination of Mattress Firm (NASDAQ: MFRM) contracts.
  • Opus Bank (NASDAQ: OPB) fell 23.9 percent to $20.75. Opus Bank reported a Q4 loss of $0.55 per share.
  • Rite Aid Corporation (NYSE: RAD) dropped 16.4 percent to $5.79. In a merger amendment publicized Monday morning, Walgreens Boots Alliance Inc (NASDAQ: WBA) and Rite Aid agreed to reduce the value of Rite Aid shares between $6.50 and $7 and to divest a total of 1,200 stores. The initial agreement proposed a divestment of 1,000. The companies also announced the extension of the transaction deadline to July 31.
  • Rewalk Robotics Ltd (NASDAQ: RWLK) fell 13 percent to $2.00. Rewalk Robotics shares have declined 77.02 percent over the past 52 weeks, while the S&P 500 index has gained 18.32 percent in the same period.
  • Fitbit Inc (NYSE: FIT) shares tumbled 12.1 percent to $6.34 after the company surprised investors with a downward revision to its fourth-quarter guidance and a plan to slash around 6 percent of its


continue reading





Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In Alzheimer’s Where Competitors Fail

Courtesy of Benzinga.

Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In Alzheimer's Where Competitors Fail

Alzheimer’s has proven to be one of the most stubborn diseases known to modern medicine. An incurable, devastating illness that inspires frustration — even anger — against and from the scientific community itself, which has failed to develop new, effective therapies.

Susanne Wilke, Ph.D., CEO of Neurotrope Inc (OTC: NTRPD), a biopharmaceutical company with an Alzheimer’s treatment called Bryostatin currently in clinical development, described Alzheimer’s to Benzinga as “a runaway disease” in a recent interview.

But some have begun to question whether the lack of progress has been due to a herd mentality among researchers, still operating under a ceiling of assumptions that date back to the 1980s as to what causes the disease and how best to treat it.

Eli Lilly’s Failure Sends Tremors Through The Space

It seemed like the drug failure heard round the world. Last November, solanezumab, the much-touted Alzheimer’s treatment from Eli Lilly And Co (NYSE: LLY), failed to meet its primary endpoint in a late-stage study, with patients not experiencing a significant slowing in cognitive decline.

Competitor Neurotrope even responded to the failure in a press release. Daniel Alkon, M.D., Neurotrope’s chief scientific officer, commended Eli Lilly’s dedication and persistence in attempting to find a cure. According to Alkon, Eli Lilly’s drug failure was one of a succession of failed attempts to treat Alzheimer’s by targeting amyloid plaques, an approach that continues to lead to disappointing outcomes.

Eli Lilly shares plunged more than 10 percent on the news, with pharmaceutical peers like Biogen Inc (NASDAQ: BIIB) and Merck & Co., Inc. (NYSE: MRK) falling 3 percent in sympathy before recovering. In the eyes of some, solanezumab’s failure…
continue reading





 
 
 

ValueWalk

#1 Performing Global Macro Hedge Fund Sees More Shorts Opportunities Ahead As China Bursts

By Jacob Wolinsky. Originally published at ValueWalk.

Crescat Global Macro Fund update to investors on 1/19/2019

Crescat Global Macro Fund and Crescat Long/Short fund delivered strong returns for both December and full year 2018 in a difficult market. Based on ...



more from ValueWalk

Zero Hedge

Johns Hopkins, Bristol-Myers Face $1 Billion Suit For Infecting Guatemalan Hookers With Syphilis 

Courtesy of ZeroHedge. View original post here.

A federal judge in Maryland said Johns Hopkins University, pharmaceutical company Bristol-Myers Squibb and the Rockefeller Foundation must face a $1 billion lawsuit over their roles in a top-secret program in the 1940s ran by the US government that injected hundreds of Guatemalans with syphilis, reported Reuters.

Several doctors from Hopkins an...



more from Tyler

Phil's Favorites

Divisive economics

 

Guest author David Brin — scientist, technology consultant, best-selling author and futurist — explores the records of Democrats and Republicans on the US economy in the following post. For David's latest posts, visit the CONTRARY BRIN blog. For his books and short stories, visit his web...



more from Ilene

Kimble Charting Solutions

Stock declines did not break 9-year support, says Joe Friday

Courtesy of Chris Kimble.

We often hear “Stocks take an escalator up and an elevator down!” No doubt stocks did experience a swift decline from the September highs to the Christmas eve lows. Looks like the “elevator” part of the phrase came true as 2018 was coming to an end.

The first part of the “stocks take an escalator up” seems to still be in play as well despite the swift decline of late.

Joe Friday Just The Facts Ma’am- All of these indices hit long-term rising support on Christmas Eve at each (1), where support held and rallies have followed.

If you find long-term perspectives helpf...



more from Kimble C.S.

Digital Currencies

Transparency and privacy: Empowering people through blockchain

 

Transparency and privacy: Empowering people through blockchain

Blockchain technologies can empower people by allowing them more control over their user data. Shutterstock

Courtesy of Ajay Kumar Shrestha, University of Saskatchewan

Blockchain has already proven its huge influence on the financial world with its first application in the form of cryptocurrencies such as Bitcoin. It might not be long before its impact is felt everywhere.

Blockchain is a secure chain of digital records that exist on multiple computers simultaneously so no record can be erased or falsified. The...



more from Bitcoin

Insider Scoop

Cars.com Explores Strategic Alternatives, Analyst Sees Possible Sale Price Around $30 Per Share

Courtesy of Benzinga.

Related 44 Biggest Movers From Yesterday 38 Stocks Moving In Wednesday's Mid-Day Session ...

http://www.insidercow.com/ more from Insider

Chart School

Weekly Market Recap Jan 13, 2019

Courtesy of Blain.

In last week’s recap we asked:  “Has the Fed solved all the market’s problems in 1 speech?”

Thus far the market says yes!  As Guns n Roses preached – all we need is a little “patience”.  Four up days followed by a nominal down day Friday had the market following it’s normal pattern the past nearly 30 years – jumping whenever the Federal Reserve hints (or essentially says outright) it is here for the markets.   And in case you missed it the prior Friday, Chairman Powell came back out Thursday to reiterate the news – so…so… so… patient!

Fed Chairman Jerome Powell reinforced that message Thursday during a discussion at the Economic Club of Washington where he said that the central bank will be “fle...



more from Chart School

Members' Corner

Why Trump Can't Learn

 

Bill Eddy (lawyer, therapist, author) predicted Trump's chaotic presidency based on his high-conflict personality, which was evident years ago. This post, written in 2017, references a prescient article Bill wrote before Trump even became president, 5 Reasons Trump Can’t Learn. ~ Ilene 

Why Trump Can’t Learn

Donald Trump by Gage Skidmore (...



more from Our Members

Biotech

Opening Pandora's Box: Gene editing and its consequences

Reminder: We are available to chat with Members, comments are found below each post.

 

Opening Pandora's Box: Gene editing and its consequences

Bacteriophage viruses infecting bacterial cells , Bacterial viruses. from www.shutterstock.com

Courtesy of John Bergeron, McGill University

Today, the scientific community is aghast at the prospect of gene editing to create “designer” humans. Gene editing may be of greater consequence than climate change, or even the consequences of unleashing the energy of the atom.

...

more from Biotech

Mapping The Market

Trump: "I Won't Be Here" When It Blows Up

By Jean-Luc

Maybe we should simply try him for treason right now:

Trump on Coming Debt Crisis: ‘I Won’t Be Here’ When It Blows Up

The president thinks the balancing of the nation’s books is going to, ultimately, be a future president’s problem.

By Asawin Suebsaeng and Lachlan Markay, Daily Beast

The friction came to a head in early 2017 when senior officials offered Trump charts and graphics laying out the numbers and showing a “hockey stick” spike in the nationa...



more from M.T.M.

OpTrader

Swing trading portfolio - week of September 11th, 2017

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Promotions

Free eBook - "My Top Strategies for 2017"

 

 

Here's a free ebook for you to check out! 

Phil has a chapter in a newly-released eBook that we think you’ll enjoy.

In My Top Strategies for 2017, Phil's chapter is Secret Santa’s Inflation Hedges for 2017.

This chapter isn’t about risk or leverage. Phil present a few smart, practical ideas you can use as a hedge against inflation as well as hedging strategies designed to assist you in staying ahead of the markets.

Some other great content in this free eBook includes:

 

·       How 2017 Will Affect Oil, the US Dollar and the European Union

...

more from Promotions





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>